Caris Life Sciences (CAI) EBT Margin (2024 - 2026)

Caris Life Sciences' EBT Margin history runs 3 years deep, the most recent figure standing at 0.3% for Q1 2026.

• In Q1 2026, EBT Margin rose 8454.0% year-over-year to 0.3%; the TTM figure through Mar 2026 stood at 3.73% (up 6416.0% YoY), while the FY2025 annual figure was 8.38%, up 5999.0% from the prior year.
• EBT Margin for Q1 2026 stood at 0.3%, down from 27.98% in the prior quarter.
• The five-year high for EBT Margin was 27.98% in Q4 2025, with the low at 84.84% in Q1 2025.
• The 3-year median for EBT Margin is 34.01% (2024), against an average of 30.84%.
• The sharpest annual moves came in 2025 and 2026: EBT Margin soared 2658 bps in 2025, then surged 8454 bps in 2026.
• Caris Life Sciences' EBT Margin stood at 28.44% in 2024, then surged by 198 bps to 27.98% in 2025, then tumbled by 101 bps to 0.3% in 2026.
• Business Quant data shows CAI's EBT Margin at 0.3% in Q1 2026, 27.98% in Q4 2025, and 11.22% in Q3 2025.